350 related articles for article (PubMed ID: 20368009)
21. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
Brizel DM; Wasserman TH; Henke M; Strnad V; Rudat V; Monnier A; Eschwege F; Zhang J; Russell L; Oster W; Sauer R
J Clin Oncol; 2000 Oct; 18(19):3339-45. PubMed ID: 11013273
[TBL] [Abstract][Full Text] [Related]
22. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
Vacha P; Fehlauer F; Mahlmann B; Marx M; Hinke A; Sommer K; Richter E; Feyerabend T
Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464
[TBL] [Abstract][Full Text] [Related]
23. A critical component of supportive care.
Murphy BA
J Support Oncol; 2007 May; 5(5):228-9. PubMed ID: 17564152
[No Abstract] [Full Text] [Related]
24. Preventing radiation induced xerostomia.
Koukourakis MI; Danielidis V
Cancer Treat Rev; 2005 Nov; 31(7):546-54. PubMed ID: 16257125
[TBL] [Abstract][Full Text] [Related]
25. Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation.
Braaksma M; Levendag P
Semin Oncol; 2002 Dec; 29(6 Suppl 19):63-70. PubMed ID: 12577248
[TBL] [Abstract][Full Text] [Related]
26. Making a meaningful difference for the patient.
Scarantino CW
J Support Oncol; 2005; 3(3):207-8. PubMed ID: 15915822
[No Abstract] [Full Text] [Related]
27. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
Rudat V; Münter M; Rades D; Grötz KA; Bajrovic A; Haberkorn U; Brenner W; Debus J
Radiother Oncol; 2008 Oct; 89(1):71-80. PubMed ID: 18707782
[TBL] [Abstract][Full Text] [Related]
28. Histamine prevents functional and morphological alterations of submandibular glands induced by ionising radiation.
Medina VA; Prestifilippo JP; Croci M; Carabajal E; Bergoc RM; Elverdin JC; Rivera ES
Int J Radiat Biol; 2011 Mar; 87(3):284-92. PubMed ID: 21142703
[TBL] [Abstract][Full Text] [Related]
29. [Assessment of radiation injuries to the salivary glands after treatment of head and neck cancers].
Urban A; Miszczyk L; Maciejewski B
Otolaryngol Pol; 2005; 59(1):21-5. PubMed ID: 15915914
[TBL] [Abstract][Full Text] [Related]
30. Xerostomia prevention after head and neck cancer treatment.
Seikaly H
Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):250-1. PubMed ID: 12578460
[No Abstract] [Full Text] [Related]
31. The role of stem cells in the prevention and treatment of radiation-induced xerostomia in patients with head and neck cancer.
Nevens D; Nuyts S
Cancer Med; 2016 Jun; 5(6):1147-53. PubMed ID: 26880659
[TBL] [Abstract][Full Text] [Related]
32. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
Chambers MS; Garden AS; Kies MS; Martin JW
Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
[TBL] [Abstract][Full Text] [Related]
33. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
[TBL] [Abstract][Full Text] [Related]
34. [Effect of Cepharanthin to prevent radiation induced xerostomia in head and neck cancer].
Imada H; Nomoto S; Ohguri T; Yahara K; Kato F; Morioka T; Korogi Y
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1041-5. PubMed ID: 15272582
[TBL] [Abstract][Full Text] [Related]
35. Intensity-modulated radiation therapy and xerostomia.
Chambers MS; Weber RS; Garden AS
J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
[TBL] [Abstract][Full Text] [Related]
36. Modification of the submandibular gland transfer procedure.
Marzouki HZ; Elkhalidy Y; Jha N; Scrimger R; Debenham BJ; Harris JR; O'Connell DA; Seikaly H
Laryngoscope; 2016 Nov; 126(11):2492-2496. PubMed ID: 27171786
[TBL] [Abstract][Full Text] [Related]
37. Artificial salivary gland replacement for radiation-induced xerostomia.
Rubin P; Bales H; Keys H
Radiology; 1971 Dec; 101(3):695-6. PubMed ID: 5129113
[No Abstract] [Full Text] [Related]
38. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma.
Bourhis J; Rosine D
Semin Oncol; 2002 Dec; 29(6 Suppl 19):61-2. PubMed ID: 12577247
[TBL] [Abstract][Full Text] [Related]
39. Upfront submandibular salivary gland transfer in pharyngeal cancers.
Pathak KA; Bhalavat RL; Mistry RC; Deshpande MS; Bhalla V; Desai SB; Malpani BL
Oral Oncol; 2004 Oct; 40(9):960-3. PubMed ID: 15380176
[TBL] [Abstract][Full Text] [Related]
40. Amifostine reduces radiation therapy-induced dry mouth in head and neck cancer patients.
Oncology (Williston Park); 2004 Sep; 18(10):1314, 1316. PubMed ID: 15526835
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
